GMCQX
Price
$13.91
Change
-$0.04 (-0.29%)
Updated
Sep 5 closing price
Net Assets
195.35M
VVIAX
Price
$71.19
Change
-$0.24 (-0.34%)
Updated
Sep 5 closing price
Net Assets
202.84B
Interact to see
Advertisement

GMCQX vs VVIAX

Header iconGMCQX vs VVIAX Comparison
Open Charts GMCQX vs VVIAXBanner chart's image
GMO US Equity VI
Price$13.91
Change-$0.04 (-0.29%)
VolumeN/A
Net Assets195.35M
Vanguard Value Index Adm
Price$71.19
Change-$0.24 (-0.34%)
VolumeN/A
Net Assets202.84B
GMCQX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GMCQX vs. VVIAX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GMCQX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 203B vs. GMCQX (195M). VVIAX pays higher dividends than GMCQX: VVIAX (2.10) vs GMCQX (1.07). GMCQX was incepted earlier than VVIAX: GMCQX (22 years) vs VVIAX (25 years). GMCQX (0.50) is less costly to investors than VVIAX (0.05). GMCQX is a more actively managed with annual turnover of: 89.00 vs. VVIAX (9.00). VVIAX has a lower initial minimum investment than GMCQX: VVIAX (3000) vs GMCQX (300000000). VVIAX annual gain was more profitable for investors over the last year : 7.74 vs. GMCQX (3.68). VVIAX return over 5 years is better than : 70.16 vs. GMCQX (20.28).
GMCQXVVIAXGMCQX / VVIAX
Total Expense Ratio0.400.05800%
Annual Report Gross Expense Ratio0.500.051,000%
Fund Existence22 years25 years-
Gain YTD6.1287.85078%
Front LoadN/AN/A-
Min. Initial Investment300000000300010,000,000%
Min. Initial Investment IRAN/AN/A-
Net Assets195M203B0%
Annual Yield % from dividends1.072.1051%
Returns for 1 year3.687.7448%
Returns for 3 years22.4936.6161%
Returns for 5 years20.2870.1629%
Returns for 10 years11.35131.619%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALGS11.340.60
+5.59%
Aligos Therapeutics Inc
AEG7.52-0.03
-0.40%
Aegon Ltd
LFST5.37-0.10
-1.83%
LifeStance Health Group
TATT33.82-0.81
-2.34%
TAT Technologies Ltd
CNET1.51-0.06
-3.81%
ZW Data Action Technologies Inc